Trial intelligence / Profile preview

Lacosamide adjunctive therapy in infants and young children with partial-onset seizures

2013-000717-20Phase 3Completed

Sponsor
UCB
Start
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Focal Onset Epilepsy and epilepsy comparing Lacosamide adjunctive therapy with Placebo adjunctive therapy (2 arms). Primary endpoint: Responder rate based on electrographic partial-onset seizures. Started Mar 2015; status: completed.

02

Drugs

lacosamide
03

Conditions

Focal Onset Epilepsyepilepsy

Beyond the preview

Go deeper on 2013-000717-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-000717-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call